News from NHS Networks: Cancer

In its latest draft guidance, the National Institute for Health and Clinical Excellence (NICE) intends to advise the NHS against routinely prescribing a drug that can be used to delay the growth of a particular type of breast cancer.
NICE has set out recommendations for the treatment of colorectal cancer from diagnosis through to management, ongoing care and support.